Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy NovaBay Pharmaceuticals stock

Learn how to easily invest in NovaBay Pharmaceuticals stock.

NovaBay Pharmaceuticals Inc is a biotechnology business based in the US. NovaBay Pharmaceuticals shares (NBY) are listed on the NYSE MKT and all prices are listed in US Dollars. NovaBay Pharmaceuticals employs 22 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in NovaBay Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NBY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

NovaBay Pharmaceuticals stock price (NYSE MKT: NBY)

Use our graph to track the performance of NBY stocks over time.

NovaBay Pharmaceuticals shares at a glance

Information last updated 2022-01-11.
Latest market close$0.34
52-week range$0.35 - $1.79
50-day moving average $0.48
200-day moving average $0.62
Wall St. target price$3.10
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.17

Buy NovaBay Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NovaBay Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NovaBay Pharmaceuticals price performance over time

Historical closes compared with the close of $0.34 from 2022-01-14

1 week (2022-01-06) N/A
1 month (2021-12-16) -24.44%
3 months (2021-10-15) -38.38%
6 months (2021-07-16) -41.38%
1 year (2021-01-15) -62.77%
2 years (2020-01-17) -45.87%
3 years (2019-01-17) 1.03
5 years (2017-01-17) 3.7

NovaBay Pharmaceuticals financials

Revenue TTM $7.7 million
Gross profit TTM $6 million
Return on assets TTM -31.66%
Return on equity TTM -63.84%
Profit margin -96.77%
Book value $0.21
Market capitalisation $16.8 million

TTM: trailing 12 months

NovaBay Pharmaceuticals share dividends

We're not expecting NovaBay Pharmaceuticals to pay a dividend over the next 12 months.

Have NovaBay Pharmaceuticals's shares ever split?

NovaBay Pharmaceuticals's shares were split on a 1:25 basis on 20 December 2015. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NovaBay Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NovaBay Pharmaceuticals shares which in turn could have impacted NovaBay Pharmaceuticals's share price.

NovaBay Pharmaceuticals share price volatility

Over the last 12 months, NovaBay Pharmaceuticals's shares have ranged in value from as little as $0.35 up to $1.79. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NovaBay Pharmaceuticals's is 3.4764. This would suggest that NovaBay Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

NovaBay Pharmaceuticals overview

NovaBay Pharmaceuticals, Inc. , a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx Clinical Reset, a gentle and soothing facial spray; and NeutroPhase and PhaseOne for the wound care market. It also offers KN95 Masks. The company sells its products through distribution partners, as well as offers Avenova and CelleRx Clinical Reset through online sales channels. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.

Frequently asked questions

What percentage of NovaBay Pharmaceuticals is owned by insiders or institutions?
Currently 21.099% of NovaBay Pharmaceuticals shares are held by insiders and 2.651% by institutions.
How many people work for NovaBay Pharmaceuticals?
Latest data suggests 22 work at NovaBay Pharmaceuticals.
When does the fiscal year end for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals's fiscal year ends in December.
Where is NovaBay Pharmaceuticals based?
NovaBay Pharmaceuticals's address is: 2000 Powell Street, EmeryVille, CA, United States, 94608
What is NovaBay Pharmaceuticals's ISIN number?
NovaBay Pharmaceuticals's international securities identification number is: US66987P2011
What is NovaBay Pharmaceuticals's CUSIP number?
NovaBay Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 628729105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site